Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Evaluation of the differential diagnosis of hyperammonemia
and hereditary orotic aciduria.
When orotic acid is measured after a protein load or allopurinol
administration, excretion of orotic acid is a very sensitive
indicator of ornithine transcarbamylase (OTC) activity. The
allopurinol test can be used to determine whether a female is
heterozygous for X-linked OTC deficiency when an OTC deficient
patient has been identified in her family.
Orotic acid is an intermediate in pyrimidine biosynthesis.
The major clinical application of the determination of orotic acid is in
the differential diagnosis of hyperammonemia because increased urinary
excretion of orotic acid is observed in most inborn errors of the urea
cycle as well as the transport defects of dibasic amino acids (lysinuric
protein intolerance, and hyperornithinemia, hyperammonemia,
homocitrullinuria [HHH] syndrome). Orotic acid is formed from
carbamoyl phosphate which accumulates in these urea cycle
disorders. Accordingly, deficiency of the first enzyme in the urea
cycle carbamoyl phosphate synthetase and of N-acetylglutamate
synthetase do not present with orotic aciduria.
Patients with hereditary orotic aciduria (uridine monophosphate
synthase [UMPS] deficiency) also excrete orotic acid excessively.
This disorder is characterized by megaloblastic anemia which
becomes apparent weeks to months after birth, failure to thrive, and
developmental delay.
<2 weeks: 1.4-5.3 mmol/mol creatinine
2 weeks-1 year: 1.0-3.2 mmol/mol creatinine
2-10 years: 0.5-3.3 mmol/mol creatinine
> or = 11 years: 0.4-1.2 mmol/mol creatinine
The value for the orotic acid concentration is reported. The
interpretation of the result must be correlated with clinical and
other laboratory findings.
No significant cautionary statements
1. Brusilow SW, Horwich AL: Urea cycle enzymes. In The Metabolic
and Molecular Bases of Inherited Disease. 8th edition. Edited by
CR Scriver, AL Beaudet, WS Sly, et al. McGraw-Hill Book Company,
2001, pp 1909-1964
2. Webster DR, Becroft DMO, van Gennip AH, van Kuilenberg ABP:
Hereditary orotic aciduria and other disorders of pyrimidine
metabolism. In The Metabolic and Molecular Bases of Inherited
Disease. 8th edition. Edited by CR Scriver, AL Beaudet, WS Sly, et al.
McGraw-Hill Book Company, 2001, pp 2663-2702